Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $137.9100 (-0.8%) ($137.7000 - $139.4600) on Wed. Aug. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.33% (three month average) | RSI | 49 | Latest Price | $137.9100(-0.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(33%) DIA(27%) SPLV(25%) XLP(25%) VYM(24%) | Factors Impacting ABBV price | ABBV will decline at least -0.665% in a week (0% probabilities). VIXM(-16%) UUP(-14%) TBT(-3%) UNG(-1%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.665% (StdDev 1.33%) | Hourly BBV | -1.1 () | Intraday Trend | -0.8% | | | |
|
1 - 5 Day Possible Target | $137.37(-0.39%) | Resistance Level | $141.19 | 5 Day Moving Average | $140.08(-1.55%) | 10 Day Moving Average | $141.06(-2.23%) | 20 Day Moving Average | $141.19(-2.32%) | To recent high | -10.5% | To recent low | 0.2% | Market Cap | $243.312b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |